Stay informed about QRATIV's latest drug repurposing research and platform developments
Our systematic drug repurposing platform has successfully identified new therapeutic applications for existing drugs, demonstrating the power of combining Mayo Clinic expertise with Inference's knowledge synthesis capabilities.
Our partnership with Mayo Clinic continues to strengthen, providing access to proprietary electronic health records and clinical expertise that enhances our drug repurposing platform's effectiveness.
We've integrated advanced AI-powered knowledge graphs into our platform, significantly improving our ability to identify novel therapeutic applications for existing drugs across multiple disease areas.
Our platform now incorporates comprehensive real-world evidence (RWE) data, enabling more accurate predictions of drug effectiveness in real-world clinical settings.
QRATIV will present our systematic approach to drug repurposing at the upcoming International Conference on Drug Discovery, showcasing how we're moving beyond serendipitous discovery to purposeful repurposing.
Our research validates the significant treatment gap in healthcare, with our platform specifically designed to address the fact that only 1 in 20 diseases currently have effective treatments.